WashU Research Funding Tops $1 Billion First Time

Randall Bateman, MD (right), director of the Dominantly Inherited Alzheimer Network (DIAN) and founding director of the DIAN-Trials Unit (DIAN-TU), confers with research technician Olatayo Ajenifuja. In his lab in the Jeffrey T. Fort Neuroscience Research Building, Bateman trains junior faculty, postdoctoral fellows, graduate students and undergraduates as they investigate the causes and methods of diagnosis and treatment of Alzheimer's disease by using a wide variety of assays and techniques. (Photo: Matt Miller/Washington University School of Medicine)
Randall Bateman, MD (right), director of the Dominantly Inherited Alzheimer Network, confers with research technician Olatayo Ajenifuja. Bateman's research into the causes and treatment of Alzheimer's disease is funded, in part, by the National Institutes of Health (NIH). (Photo: Matt Miller/WashU Medicine)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.